11520 related articles for article (PubMed ID: 1705764)
1. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
3. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
Stadler R; Garbe C
Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
[TBL] [Abstract][Full Text] [Related]
4. [HMB 45 positive balloon cells in combined nevi].
Laaff H; Kühnl-Petzoldt C
Hautarzt; 1992 Sep; 43(9):566-8. PubMed ID: 1399602
[TBL] [Abstract][Full Text] [Related]
5. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
[TBL] [Abstract][Full Text] [Related]
6. [Pitfalls in the diagnosis of malignant melanoma].
Orosz Z
Magy Onkol; 2003; 47(1):27-39. PubMed ID: 12704452
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of cerbB3 in naevi and malignant melanomas.
Korabiowska M; Mirecka J; Brinck U; Hoefer K; Marx D; Schauer A
Anticancer Res; 1996; 16(1):471-4. PubMed ID: 8615656
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
12. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Mirecka J; Korabiowska M; Schauer A
Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
[TBL] [Abstract][Full Text] [Related]
13. Type VII collagen antibody LH 7.2 identifies basement membrane characteristics of thin malignant melanomas.
Kirkham N; Price ML; Gibson B; Leigh IM; Coburn P; Darley CR
J Pathol; 1989 Mar; 157(3):243-7. PubMed ID: 2647941
[TBL] [Abstract][Full Text] [Related]
14. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
[TBL] [Abstract][Full Text] [Related]
16. Common and uncommon variants of melanocytic naevi.
Strungs I
Pathology; 2004 Oct; 36(5):396-403. PubMed ID: 15370108
[TBL] [Abstract][Full Text] [Related]
17. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
Steuhl KP; Rohrbach JM; Knorr M
Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
[TBL] [Abstract][Full Text] [Related]
19. Equine skin tumours in 20 horses resembling three variants of human melanocytic naevi.
Schöniger S; Summers BA
Vet Dermatol; 2009 Jun; 20(3):165-73. PubMed ID: 19374725
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
